Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Pharmaceutical Research & Manufacturers of America

Pharmaceutical & Health Products · Registrant & Client

B
Influence Score
69/100
High Influence
$135.8M
Total Lobby Spend
9
Policy Issues
60
Lobbyists
14
Revolving Door

Pharmaceutical Research & Manufacturers of America reported $135.8 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 9 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Labor
Dept of Commerce
Federal Communications Commission
Dept of Transportation
Federal Aviation Administration
Office of the U.S. Trade Representative
White House Office
Federal Trade Commission
Dept of Energy
Centers for Medicare & Medicaid Services
Federal Energy Regulatory Commission

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecPharmaceutical Research & Manufacturers of America
BUDMEDSCI
3$6.7M
2024 Jul-SepPharmaceutical Research & Manufacturers of America
MEDPHA
2$6.6M
2024 Apr-JunPharmaceutical Research & Manufacturers of America
BUDMEDSCI+1
4$5.2M
2024 Jan-MarPharmaceutical Research & Manufacturers of America
SCIMMMHCR+1
1$5.3M
2023 Oct-DecPharmaceutical Research & Manufacturers of America
HCRPHASCI+2
2$7.3M
2023 Jul-SepPharmaceutical Research & Manufacturers of America
TAXBUDMED+2
3$7.4M
2023 Apr-JunPharmaceutical Research & Manufacturers of America
BUDMMM
3$7.7M
2023 Jan-MarPharmaceutical Research & Manufacturers of America
MMMHCRBUD+1
3$6.2M

Pharmaceutical Research & Manufacturers of America Lobbying FAQ

Pharmaceutical Research & Manufacturers of America has spent $135.8M on federal lobbying across 9 policy areas. This includes spending on registered lobbyists and direct government contacts.

Pharmaceutical Research & Manufacturers of America lobbies on 9 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Medicare/Medicaid. These disclosures are filed quarterly with the Senate Office of Public Records.

Pharmaceutical Research & Manufacturers of America has an Influence Score of 69/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Pharmaceutical Research & Manufacturers of America employs 60 registered lobbyists, of whom 14 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Pharmaceutical Research & Manufacturers of America has contacted 11 government entities as part of their lobbying activities, including Dept of Labor, Dept of Commerce, Federal Communications Commission.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.